Antibodies to surface dopamine-2 receptor in autoimmune movement and psychiatric disorders
November 30, 2012
Dale et al
Brain. 2012 Nov;135(Pt11):3453-68.
https://academic.oup.com/brain/article/135/11/3453/272463
Recent reports of autoantibodies that bind to neuronal surface receptors or synaptic proteins have defined treatable forms of autoimmune encephalitis. Despite these developments, many cases of encephalitis remain unexplained. We have previously described a basal ganglia encephalitis with dominant movement and psychiatric disease, and proposed an autoimmune aetiology. Given the role of dopamine and dopamine receptors in the control of movement and behaviour, we hypothesized that patients with basal ganglia encephalitis and other putative autoimmune basal ganglia disorders harboured serum autoantibodies against important dopamine surface proteins.
– Abstract from academic.oup.com
